Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
J&J beats first-quarter profit estimates on cancer drugs strength
06:22am, Tuesday, 16'th Apr 2024
Johnson & Johnson reported a first-quarter profit above Wall Street estimates on Tuesday, helped by strong sales of its cancer drugs including top-selling blood cancer treatment Darzalex.
Mizuho's health care earnings playbook ahead of UnitedHealth, J&J results
06:43pm, Monday, 15'th Apr 2024
Jared Holz, Mizuho, joins 'Fast Money' to talk what to expect from the upcoming slate of health care earnings.
Should You Buy Johnson & Johnson (JNJ) Ahead of Earnings?
11:11am, Monday, 15'th Apr 2024
Johnson & Johnson (JNJ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's What To Expect From Johnson & Johnson's Q1
11:00am, Monday, 15'th Apr 2024
Johnson & Johnson stock (NYSE: JNJ) will report its Q1 2024 results on Tuesday, April 16. We expect the company to post revenue of $21.5 billion and earnings of $2.68, compared to the consensus estima
Johnson & Johnson Reports Earnings Tuesday. What to Expect.
10:32am, Monday, 15'th Apr 2024
Pharmaceuticals firm Johnson & Johnson kicks off earnings season for the sector on Tuesday. Investors want executives to put to rest ongoing talc litigation.
3 Blue Chip Stocks For Your April 2024 Watchlist
10:23am, Monday, 15'th Apr 2024
Blue Chip stocks to watch in the stock market today.
5 U.S. Bigwigs Likely to Gain on Q1 Earnings Beat This Week
09:21am, Monday, 15'th Apr 2024
We have narrowed our search to five large-cap stocks that are poised to beat on earnings results this week. These are: BAC, JNJ, UAL, PNC, BK.
Rwanda joins other African countries in recalling J&J children's cough syrup
07:04am, Monday, 15'th Apr 2024
Rwanda's drug regulator has recalled a batch of Johnson & Johnson children's cough syrup as a precautionary measure after its Nigerian counterpart said laboratory tests found high levels of toxicity.
The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash
09:00am, Sunday, 14'th Apr 2024
The S&P 500 is doing great this year after last year's historic run higher. The broad index is up almost 9% in 2024.
South Africa recalls J&J's cough syrup sold in six African nations after suspected toxicity
02:50pm, Saturday, 13'th Apr 2024
South Africa's health regulator said on Saturday it is recalling batches of Johnson & Johnson's children's cough syrup after detection of high levels of diethylene glycol.
3 Quarterly Releases to Watch Next Week
04:01pm, Friday, 12'th Apr 2024
Earnings season is always an exciting time for investors, with companies finally revealing what's transpired behind closed doors. And concerning next week's docket, these three notable companies are s
55 April Dividend Kings: Buy 8, Watch 8
02:39pm, Friday, 12'th Apr 2024
"What is a Dividend King? A stock with 50 or more consecutive years of dividend increases."—suredividend.com. The 55 Dividend Kings screened as of April 10 represented 9 of 11 Morningstar Sectors. B
Earnings setup: UnitedHealth, Johnson & Johnson, Genuine Parts, P&G, Taiwan Semi & American Express
02:00pm, Friday, 12'th Apr 2024
The Investment Committee give you their earnings setup for next week.
J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
10:11am, Friday, 12'th Apr 2024
J&J's (JNJ) Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Stelara. Surgical procedure recovery and new products are likely to have driven MedTech sales.
Johnson & Johnson: Doubling Down On This 2024 Dog Of The Dow
08:00am, Friday, 12'th Apr 2024
Johnson & Johnson: Doubling Down On This 2024 Dog Of The Dow
